Juvenile chronic arthritis (JCA) contains a subset of patients with circulating antinuclear antibodies (ANAs). had an established diagnosis of JCA according to American Rheumatism Association critera,4 with disease onset before the age of 16 and a mean disease duration of 6-5 years. The mean age was 11-0 years (range 1-21) in boys and 12-8 years (2-23) in girls. Eleven patients had monarticular JCA, 53 had pauciarticular JCA, and 57 had polyarticular JCA at the time of investigation. Table 1 gives further clinical details.
All patient records were reviewed by one of us (M0) and evaluated for the type of disease onset, extra-articular manifestations, results of tests for autoantibodies, and actual drug treatment. Evaluation of disease activity was based on a global assessment, including the active joint count, duration of morning stiffness, functional impairment, and laboratory parameters such as erythrocyte sedimentation rate (Westergren), haemoglobin, and platelet counts. Disease activity was graded as none (0), moderate (1), or severe (2) . No separate grading of the activity of eye involvement was made in patients with anterior uveitis.
A serum sample was taken from each patient and analysed for the presence of autoantibodies immediately. An additional serum sample was kept frozen at -20°C until used. 114 Twenty six (21%) of the patients had inactive disease, 62 (51%) had moderate, and 33 (27%) severe disease activity. Severe disease activity was almost exclusively found in the polyarticular group. Eighty eight (73%) patients had no organ involvement, one had had pleuropericarditis, three had amyloidosis, one had mononeuritis, and 30 (25%) had previous or ongoing anterior uveitis with severe impairment of vision in six cases.
AUTOANTIBODIES
ANAs had been or were still (10 patients) present in 61 (50%) of all patients, whereas only 10 (8%) were positive for rheumatoid factor. None of the ANA positive patients had anti-native DNA antibodies. 
ANTIHISTONE ANTIBODIES
AHAs were detected in altogether 58 patients, 45 of whom had also been positive for ANAs at some point of their disease. The AHA positive group was divided into 28 patients with uveitis (group A) and 30 patients without uveitis (group B). The two groups were comparable with regard to disease activity and drug regimens. An equal distribution of ANA titres recorded during the disease was found, with a median ANA titre of 64 (range 16-1024) in 27 patients in group A and 18 in group B. Figure 1 and Table 2 show the pattern of AHAs in the two groups of patients with JCA. When groups A and B were compared it was found that 9 v 22 patients had AHAs which showed reactivity to only one histone, 16 v 6 had AHAs directed against two histones, and 3 v 2 had AHAs directed against three or more histone classes. The highest reactivity was found to be directed against H3 in group A (Fig. 1) . In group B the reactivity to anti-Hi and anti-H3 was equally frequent and of the same magnitude (Fig. 1,  Table 2 ).
When the 30 patients with JCA and uveitis were compared with the 91 patients with JCA without uveitis ( Table 3 ) the uveitis group differed from the non-uveitis group by an excess of ANA and AHA positivity, a predominantly pauciarticular type of 8 Weill and Menkes found a higher percentage of AHA and ANA positivity in their study of 47 patients with JCA with mono/pauciarticular disease.9 They did not comment on the presence or absence of uveitis, however, nor did they report the antihistone response pattern. In another study 6 (15%) of 41 patients with JCA displayed antihistone reactivity, mainly against H2B.10 In our study the prevailing antibody in the entire AHA positive group was anti-H3.
A high proportion of ANA positive patients with JCA, yet not all, develop anterior uveitis.7 We therefore analysed an AHA positive subgroup of 28 patients with JCA with a history of anterior uveitis (group A) and compared them with 30 AHA positive patients with JCA without uveitis (group B). Despite minor differences in the presenting clinical picture, including actual disease activity, type of joint affection, and drug treatment, a distinct autoimmune response to histones was found in the two groups. Analysis of the pattern of AHAs showed a predominance of anti-H3, which alone or 
